3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
Mitomycin
7
Hyperthermic Intraperitoneal Chemotherapy
5
Oxaliplatin
4
Doxorubicin
3
Cisplatin
3
Trastuzumab
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
tipifarnib
1
sodium thiosulfate
1
nilotinib
1
motexafin lutetium
1
irinotecan sucrosofate
1
entinostat
1
durvalumab
1
dehydroftorafur
1
Surveys and Questionnaires
1
Referral and Consultation
1
Quality of Life
1
Psychiatric Rehabilitation
1
Platinum
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Ondansetron
1
Nutritional Status
1
Molecular Diagnostic Techniques
1
Mitozytrex
1
Melphalan
1
Laparoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Appendiceal Neoplasms
×
Referral and Consultation
×
Gynecologic
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled